Condition
Insulin-Like Growth Factor I
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Completed2
Unknown1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07043504Not Yet RecruitingPrimary
Study on Dynamic Changes of Serum IGF-1 Post-Cerebral Hemorrhage and Its Prognostic Correlation
NCT05599282Phase 2CompletedPrimary
The Efficacy and Safety of an Amino Acid Supplement in Adults
NCT05038306Phase 2Completed
Chinese Medicine WT for Spinocerebellar Ataxia Type 3
NCT01718015UnknownPrimary
Neurotrophic Factors in Cerebrospinal Fluid in Diabetic Patients With Polyneuropathy
Showing all 4 trials